Table 2.
Description of pharmacist interventions (PI).
| Drug-Related Problem | N (%) | PI | N (%) | |
|---|---|---|---|---|
|
PI with Prescribers
n = 83 (87%) |
Contra-indication/non-conformity to guidelines | 22 (27) | Addition of a new drug | 30 (36) |
| Dosage problem (under or over dosage) | 12 (14) | Discontinuation or refusal to deliver | 18 (22) | |
| Drug or medical device not received by the patient | 12 (14) | Dose adjustment | 16 (19) | |
| Drug omission | 9 (11) | Drug monitoring | 9 (11) | |
| Monitoring | 9 (11) | Drug switch | 7 (8) | |
| Improper prescription | 6 (7) | Optimization of the dispensing/administration mode | 3 (4) | |
| Unjustified drug prescription | 5 (6) | |||
| Adverse drug reaction | 4 (5) | |||
| Drug interaction | 3 (4) | |||
| Therapeutic redundancy | 1 (1) | |||
|
PI with Patients
n = 12 (13%) |
Improper prescription | 12 (100) | Optimization of the dispensing/administration mode | 12 (100) |
|
Clinical Impact of PI
n = 95 |
Moderate | 64 (67) | ||
| Major | 18 (19) | |||
| Minor | 13 (14) | |||